Cargando…
Insight into purification of monoclonal antibodies in industrial columns via studies of Protein A binding capacity by in situ ATR-FTIR spectroscopy
Therapeutic monoclonal antibodies (mAbs) are effective treatments for a range of cancers and other serious diseases, however mAb treatments cost on average ∼$100 000 per year per patient, limiting their use. Currently, industry favours Protein A affinity chromatography (PrAc) as the key step in down...
Autores principales: | Beattie, James W., Rowland-Jones, Ruth C., Farys, Monika, Tran, Richard, Kazarian, Sergei G., Byrne, Bernadette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351638/ https://www.ncbi.nlm.nih.gov/pubmed/34296229 http://dx.doi.org/10.1039/d1an00985k |
Ejemplares similares
-
In-column ATR-FTIR spectroscopy to monitor affinity chromatography purification of monoclonal antibodies
por: Boulet-Audet, Maxime, et al.
Publicado: (2016) -
Cleaning-in-place of immunoaffinity resins monitored by in situ ATR-FTIR spectroscopy
por: Boulet-Audet, Maxime, et al.
Publicado: (2015) -
ATR-FTIR spectroscopy and spectroscopic imaging for the analysis of biopharmaceuticals
por: Tiernan, Hannah, et al.
Publicado: (2020) -
Causes of Industrial
Protein A Column Degradation,
Explored Using Raman Spectroscopy
por: Beattie, James W., et al.
Publicado: (2022) -
Application of Raman Spectroscopy to Dynamic Binding Capacity Analysis
por: Beattie, James W., et al.
Publicado: (2023)